Literature DB >> 33926748

It's time to re-evaluate cervical Cancer screening after age 65.

Sarah Dilley1, Warner Huh2, Batel Blechter3, Anne F Rositch3.   

Abstract

Cervical cancer screening guidelines currently recommend cessation of cervical cancer screening after age 65, despite 20% of new cervical cancer cases occurring in this age group. The US population is aging, research methodology that examines cervical cancer incidence and mortality rates has changed, and sexual behaviors and the rates at which women have hysterectomies have changed over time. Current guidelines do not adequately address these changes, and may be missing significant opportunities to prevent cervical cancer cases and deaths in older women. Furthermore, racial disparities in cervical cancer outcomes may be exacerbated by not addressing the preventive health needs of older women through cervical cancer screening.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  Cervical cancer; Cervical cancer screening; Over 65; Prevention

Mesh:

Year:  2021        PMID: 33926748      PMCID: PMC9195478          DOI: 10.1016/j.ygyno.2021.04.027

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.304


  25 in total

1.  Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.

Authors:  Kemi M Doll; Aaron N Winn
Journal:  Am J Obstet Gynecol       Date:  2019-05-22       Impact factor: 8.661

2.  How confident can we be in the current guidelines for exiting cervical screening?

Authors:  Patti E Gravitt; Rebecca Landy; Mark Schiffman
Journal:  Prev Med       Date:  2018-07-05       Impact factor: 4.018

3.  Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.

Authors:  Ana Cecilia Rodríguez; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillén; Mario Alfaro; Jorge Morales; Martha Hutchinson; Hormuzd Katki; Li Cheung; Sholom Wacholder; Robert D Burk
Journal:  J Natl Cancer Inst       Date:  2010-02-15       Impact factor: 13.506

4.  Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Maureen G Phipps; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-08-21       Impact factor: 56.272

5.  A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.

Authors:  Patti E Gravitt; Anne F Rositch; Michelle I Silver; Morgan A Marks; Kathryn Chang; Anne E Burke; Raphael P Viscidi
Journal:  J Infect Dis       Date:  2012-12-12       Impact factor: 5.226

6.  Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.

Authors:  Anne F Rositch; Rebecca G Nowak; Patti E Gravitt
Journal:  Cancer       Date:  2014-05-12       Impact factor: 6.860

7.  An evaluation of cervical cancer in women age sixty and over.

Authors:  Katrina V Fox; Chirag A Shah; Elizabeth M Swisher; Rochelle L Garcia; Lynn S Mandel; Heidi J Gray; Ron E Swensen; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2008-02-05       Impact factor: 5.482

8.  Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.

Authors:  Wonsuk Yoo; Sangmi Kim; Warner K Huh; Sarah Dilley; Steven S Coughlin; Edward E Partridge; Yunmi Chung; Vivian Dicks; Jae-Kwan Lee; Sejong Bae
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

9.  Cervical cancer in women over 65: An analysis of screening.

Authors:  S Yost; A Hoekstra
Journal:  Gynecol Oncol Rep       Date:  2018-05-22

10.  Cervical cancer screening history prior to a diagnosis of cervical cancer in Danish women aged 60 years and older-A national cohort study.

Authors:  Anne Hammer; Vibeke Soegaard; Rikke D Maimburg; Jan Blaakaer
Journal:  Cancer Med       Date:  2019-01-01       Impact factor: 4.452

View more
  2 in total

Review 1.  A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment.

Authors:  Hanifeh Shariatifar; Fateme Ranjbarian; Fahimeh Hajiahmadi; Alireza Farasat
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

2.  Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.

Authors:  Katie E Lichter; Kimberly Levinson; Anne Hammer; Melissa H Lippitt; Anne F Rositch
Journal:  Gynecol Oncol       Date:  2022-02-01       Impact factor: 5.482

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.